Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

By Erja Malinen, T. Rinttilä, K. Kajander, J. Mättö, Anna Kassinen, L. Krogius, Maria Saarela, R. Korpela, A. Palva. American Journal of Gastroenterology, 2005

715 citations recorded by the source corpus.

Subfields: Gastroenterology, Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/149105b25ff38aaf2f31382f4fc8e0c937c95991

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Gastroenterology

In Molecular Biology

In Surgery

Citations in the corpus

Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease (2012, background): “[135,141], Actinobacteria and Bacteroidetes [142], as”
Intestinal microbiota in human health and disease: the impact of probiotics (2011, background): “Distinct changes in microbiota composition have been observed in the different IBS subtypes compared with healthy individuals (Malinen et al. 2005; Maukonen et al. 2006; Lyra et al. 2009).”
Brain–Gut–Microbe Communication in Health and Disease (2011, background): “Colonization of the infant gut commences at birth when delivery exposes the infant to a complex microflora and its initial microbiome has a maternal signature (see Figure 1; Mändar and Mikelsaar, 1996; Mackie et al., 1999; Palmer et al., 2007).”
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions (2010, background): “The use of modern molecular techniques has also revealed abnormalities in the fecal microbiota of patients with IBS”
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics (2017, background): “prausnitzii has not been reached since both studies reported normal counts (Malinen et al., 2005; Swidsinski et al., 2005, 2008; Kassinen et al., 2007; Jia et al., 2010; Duboc et al., 2012; Rigsbee et al., 2012; Lopez-Siles et al., 2014, 2016) and studies reporting lower numbers in IBS patients of a”
The role of microbiome in central nervous system disorders (2013, neutral): “Moreover, gut microbiome alteration was observed in IBS patients, exemplified by the reduction of species under Lactobacillus genus and Clostridium class (Kassinen et al., 2007; Malinen et al., 2005).”
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota (2011, result): “These observations may explain why we recorded a significant increase in B adolescentis but not other species of Bifidobacterium in our analysis and the apparent disagreement with previous studies that demonstrated a reduction in Bifidobacterium, particularly B catenulatum, in IBS.(13) 14 48 It is u”
Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii (2008, background): “(54) BlonR TACCCGTCGAAGCCAC Malinen et al.”
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review (2008, background): “Subtle intestinal inflammation and subsequent neuromodulation have been hypothesised as the underlying pathology driving the pathophysiology of IBS.45 Probiotics can have potent anti-inflammatory properties,46 and Bifidobacterium infantis 35624 normalised circulating interleukin 12 (IL10) and IL12 l”
The first 1000 cultured species of the human gastrointestinal microbiota (2014, result): “…spp. in human health, although several studies have shown an increased abundance of Veillonella spp. in fecal samples of irritable bowel patients (Malinen et al., 2005; Tana et al., 2010; Saulnier et al., 2011), which could indicate an increased transit of the ileal microbiota to the lower part…”